It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
In a video that has gone viral, Porter is shown confronting the pharmaceutical executive on Wednesday over his financial compensation during a hearing on runaway drug prices. The California Democrat said Celgene more than tripled the price of cancer drug Revlimid to $765 a pill, from $215 in 2005, without significantly improving the treatment. Alles received a $500,000 bonus connected to higher profits from Revlimid in the last two years he served as chief executive of Celgene, Porter said.
"Do you know what this number is," Porter asked Alles after writing the figure "$13 million" on a whiteboard at her side. Alles responded that he didn't know but that it looked like his compensation.
"So to recap here, the drug didn't get any better, the cancer patients didn't get any better — you just got better at making money. You just refined your skills at price-gouging," Porter said.
A Department of Health and Human Services official said the agency "doesn't comment on the rulemaking process" when asked how soon this could take effect and what testing a payment model looks like in practice.
"The president may be frustrated that he didn't reach a deal with drugmakers as his announced action is merely a demonstration, and it is very hard to see how it could have any impact in the near future," said Ian Spatz, a health policy consultant and former drug company executive.
For a president who prides himself on his deal-making skills, the month and a half since he first signed an order on drug pricing is ending without a deal.
originally posted by: LookingAtMars
a reply to: Southern Guardian
I have never understood how they get away with charging magnitudes more in the US, for the exact same "pill"!
originally posted by: xuenchen
This what happens when insurance companies and governments start paying for prescriptions 🤫
originally posted by: xuenchen
This what happens when insurance companies and governments start paying for prescriptions 🤫
originally posted by: AScrubWhoDied
originally posted by: xuenchen
This what happens when insurance companies and governments start paying for prescriptions 🤫
Except insurance companies pay no where near those amounts. Actually, its only the end user that gets #ed over. We probably deserve it though.
originally posted by: Irishhaf
a reply to: LookingAtMars
I dont agree with it but as I heard one time it takes a couple billion to take a drug from idea to market, since most of the western world has legal limits on what they can charge, the US is one of the last to consider it.
Since the average drug only has about 10 years of marketability to make that money back, since everyone else says only a buck a pill or whatever they have to go to other areas to try and make that money back.
I dont like it, but there has to be some money coming in to fund the research and development.
Since the rest of the west rushed to mandate prices, we got hosed but hey europe has theirs they can continue to look down on us for funding their cheap drugs.
originally posted by: Irishhaf
a reply to: LookingAtMars
I dont agree with it but as I heard one time it takes a couple billion to take a drug from idea to market, since most of the western world has legal limits on what they can charge, the US is one of the last to consider it.
Since the average drug only has about 10 years of marketability to make that money back, since everyone else says only a buck a pill or whatever they have to go to other areas to try and make that money back.
I dont like it, but there has to be some money coming in to fund the research and development.
Since the rest of the west rushed to mandate prices, we got hosed but hey europe has theirs they can continue to look down on us for funding their cheap drugs.
originally posted by: AScrubWhoDied
originally posted by: Irishhaf
a reply to: LookingAtMars
I dont agree with it but as I heard one time it takes a couple billion to take a drug from idea to market, since most of the western world has legal limits on what they can charge, the US is one of the last to consider it.
Since the average drug only has about 10 years of marketability to make that money back, since everyone else says only a buck a pill or whatever they have to go to other areas to try and make that money back.
I dont like it, but there has to be some money coming in to fund the research and development.
Since the rest of the west rushed to mandate prices, we got hosed but hey europe has theirs they can continue to look down on us for funding their cheap drugs.
Not buying the "billions to market" narrative. There's likely a very good reason not a single one of these companies have ever actually published their costs.
Makes it impossible to know. Fortunately for them though, there are no shortage of "studies" that benefit them.
Despite the data not being public. Like I said, we probably deserve it.
In this study, which included 63 of 355 new therapeutic drugs and biologic agents approved by the US Food and Drug Administration between 2009 and 2018, the estimated median capitalized research and development cost per product was $985 million, counting expenditures on failed trials.
The companies aren't allowed to charge market prices in Europe, so they just raise the price in the US to cover the losses in other markets.